The EVMS Institutional Biosafety Committee (IBC) executes its function in accordance with the principles and guidelines established by the Department of Health and Human Services, National Institutes of Health and the Centers for Disease Control & Prevention. The EVMS Biosafety Procedure Manual and the EVMS Exposure Control Plan are the local resources utilized for the implementation of policy regarding the use of biohazards. These documents specify those hazards that fall under the purview of the IBC, their appropriate handling and disposal, and distinguishes them from those that are treated under the guidelines set forth by OSHA.
Any investigator that is working with the following materials should be sure to make application to the IBC for registry and approval of their scientific procedures:
- Recombinant DNA and RNA, including all methodologies that involve the isolation, amplification, hybridization, and other uses of DNA or RNA from any organism.
- Culture of human or animal pathogens.
- Laboratory-induced infection of a human or animal with any human or animal pathogen(s).
- All Human tissues and cells.
- All other tissues and cells.
- Studies referred to the IBC by one of the other regulatory committees, such as the Institutional Animal Care and Use Committee (IACUC) or the Institutional Review Board (IRB).
BioRAFT
Required Training
IBC Documents and Forms
Federal Regulations and Other Links of Interest
- NIH Guidelines for Research Involving Recombinant DNA Molecules
- NIH Office of Biotechnology Activities
- CDC, Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition
Biosafety Levels - ABSA, Risk Group Classification for Infectious Agents
- List of Select Biological Agents and Toxins
- Bloodborne Exposure Control Plan